Reaction
Treatment Related Secondary Malignancy reporting signals
As of the last recalculation, Treatment Related Secondary Malignancy appears in 203 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 172.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 16 | 172.3 | 172.6 |
| Mercaptopurine | 24 | 160.8 | 161.0 |
| Vincristine Sulfate | 28 | 113.5 | 113.6 |
| Etoposide | 53 | 99.7 | 99.7 |
| Cytarabine | 34 | 69.5 | 69.5 |
| Cortisone Acetate | 4 | 33.9 | 33.9 |